Navigation Links
International Committee Recommends Stringent Guidelines for Translating Stem Cell Therapies From the Lab Bench to the Bedside
Date:6/12/2008

PHILADELPHIA, June 12 /PRNewswire-USNewswire/ -- The Internet is rife with provider Web sites and patient testimonials touting exciting new stem cell treatments for paralysis, Parkinson's disease, heart failure and cancer. And every year, desperately ill patients travel thousands of miles to seek experimental stem cell therapies with bold claims of cures for such intractable diseases.

Few, if any, of these putative treatments are based on sound pre-clinical data that have been published in peer-reviewed journals. Today, there are no proven treatments based on stem cells other than those for blood disorders, like leukemia and immune deficiencies. All other stem cell treatments are still highly experimental.

At the sixth annual meeting of the International Society for Stem Cell Research, a task force of leaders in the field announced a draft set of guidelines to ensure that rigorous best practices are applied to the clinical translation of stem cell research from the laboratory to human subjects. The guidelines are the culmination of months of discussion by scientists, ethicists, public policymakers, clinicians, industry representatives and members of the public from 13 countries. (The full guidelines will be posted at http://www.isscr.org.)

"These guidelines are critically important to the future success of the field," according to Dr. George Q. Daley, ISSCR president and associate director of the Stem Cell Program at Children's Hospital Boston. "Not only does the use of untested therapies put patients at risk, it jeopardizes the legitimate practice of all translational stem cell research."

In strongly worded language, the guidelines "condemn" the use of stem cell therapies outside of an established clinical trial, particularly when patients are charged for "advertised medical services that constitute experimental, unproven and unestablished interventions." The guidelines call upon re
'/>"/>

SOURCE International Society for Stem Cell Research
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Maternal malaria researcher wins prestigious international prize
2. DaVita Dietitians to Speak at the International Congress on Nutrition and Metabolism in Renal Disease in France
3. 8th International Conference on Pain and Chemical Dependency
4. MINRAD International, Inc. Announces FDA Approval of Petrem(TM) Sevoflurane
5. ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations
6. HealthSTAR Public Relations Joins GlobalCom PR-Network of International Agencies
7. The International Rett Syndrome Foundation Names Antony Horton Ph.D. Chief Scientific Officer
8. International Esthetics, Cosmetics & Spa Conference - Las Vegas
9. 6 Nobel Prize Winners at International Congress of Genetics
10. Jennerex Clinical Trial Data with JX-594 Selected for Plenary Session Presentation at Major International Conference
11. International Diabetes Federation Commits to Improving Diabetes Education Globally Through Centres of Education

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...ical legislation would strengthen Medicare, improv... 8 SUMMARY: Yesterday... critical health care reform legislation that woul...nation by insurance companies that prices millions... ,, The Affordable Health Care for America Act ...
(Date:11/8/2009)... UCW Academy of Health holds open ho...Victoria, BC (Vocus) November 8, 2009 -- UCW Acade...eer in British Columbia’s health care indust...sday, November 25, 2009. , ,UCW Academy of Health...ation, nursing and social services, designs its pr...
(Date:11/8/2009)...NGTON, Nov. 7 Tonight t...Health Care for America Act, landmark health refor...access to quality, affordable, stable and secure h... down on some of the insurance industry,s worst pr...cans and cut the deficit by $104 billion over ten ...
(Date:11/8/2009)... Men’s Health Network (MHN) ur...risks, especially those linked to exposure to chem...ry service. Bladder cancer is one of those cancers...ecially those who once smoked or currently smoke c...C (PRWEB) November 8, 2009 -- Men’s Health N...
(Date:11/8/2009)...on,s largest network of Hispanic health advocates ...rm in 2009 ,, WASHINGTON, Nov. 7 /PRNewswire-U...atives showed they have heard the voice of America...for America Act. Now the Senate must deliver, with...e reform," said Dr. Jane L. Delgado, President and...
Breaking Medicine News(10 mins):Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2
...nic gastrointestinal symptoms are highly prevalent...ious gastrointestinal symptoms that greatly inconv...ude GERD, uninvestigated dyspepsia, irritable bowe...valuating the impact of chronic gastrointestinal s...
...NION CITY, Calif., Dec. 29 Abaxis, Inc.,(Nasdaq: ... point-of-care blood,analysis systems, announced t...tive officer will present at Needham & Company...ew York City. , About Abaxis , Abaxis deve...
... could help them avoid long-term complications of ...ONDAY, Dec. 29 (HealthDay News) -- Obese teenagers...ght but see their type 2 diabetes disappear, a new... eat. In this study, researchers used the Roux-en-...
...NNATI, Dec. 29 The LCA-Vision Inc. (Nasdaq: LCA...t solicitation threatened by the Joffe group. The...prudent and achievable strategic plan to return th...at the Joffe effort is an undue distraction to the...
... In the slums of Jinja, the sec...arly scarce. Through PROJECT C.U.R.E.,s partnershi...ximately $1 million worth of medical supplies and ...s of people. The first container, filled with near...
... Home of the world,s high docum...nics of Georgia (RCOG), has expanded their online ...formation and treatment options. The company is pr...lass cancer treatment and is viewed as a leader in...
Other Medicine News:Health News:Chronic gastrointestinal symptoms in Korean population 2Health News:Gastric Bypass Halts Diabetes in Obese Teens 2Health News:Gastric Bypass Halts Diabetes in Obese Teens 3Health News:LCA-Vision Urges Stockholders to Take No Action Regarding the Joffe Group's Threatened Consent Solicitation 2Health News:American-Based NGO Sends Emergency Medical Relief to Uganda 2Health News:RCOG.com and ProstRcision.com Increase Online Presence for Cancer Information 2Health News:RCOG.com and ProstRcision.com Increase Online Presence for Cancer Information 3Health News:RCOG.com and ProstRcision.com Increase Online Presence for Cancer Information 4
(Date:11/6/2009)...e-FirstCall/ -- Boston Scientific Corporation (NYS...greement in principle with the U.S. Department of ... by its Guidant subsidiary in 2005. The alleged c...Scientific,s 2006 acquisition of Guidant. ,, Bo...igation by the U.S. Attorney,s Office in Minneapol...
(Date:11/6/2009)...wire/ -- Philips Respironics applauds the efforts ...(CDC) to raise awareness about an important public...CDC,s release of the first-ever government study t...ess is a milestone in quantifying the size and sco... industry leader and sleep therapy manufacturer, P...
(Date:11/6/2009)...rstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA...ment of small-molecule therapeutics for the treatm...us (HIV), today reported recent accomplishments an... months ended September 30, 2009. ,, (Logo: ...LOGO ) ,, "Since our last quarterly update, we ...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8CRH Medical introduces non surgical hemorroid removal to Gastroenterology Fellowship program 50312 1CRH Medical introduces non surgical hemorroid removal to Gastroenterology Fellowship program 50312 2No More Drama With TOMA LECHE 50310 1No More Drama With TOMA LECHE 50310 2No More Drama With TOMA LECHE 50310 3No More Drama With TOMA LECHE 50310 4Maybe Men Arent So Picky After All 50309 1Maybe Men Arent So Picky After All 50309 2
...ers identify molecular signature in human type 1 d...dren,s Research,Institute, located in Milwaukee, r...iabetes diagnosis. Led by Martin Hessner, PhD, ass...e research team applied a new,approach, finding th...hase,create a unique genomic fingerprint. The rese...
...ESVILLE, Va., April 16 The,Foundation for Cancer ...,prostate cancer oncologist and survivor, Dr. Char... for prostate cancer at Westminster at Lake Ridge,...th the recent press around prostate cancer vaccine...Myers says. "The good news is there are many,thing...
Other Medicine Technology:Discovery Leads to Earlier Diagnosis of Type 1 Diabetes 2Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles 'Snuffy' Myers Announces Vitamin D Clinical Trials 2
...harmDx Kit is a direct fluorescence in situ hybrid...termine HER2 gene amplification in formalin-fixed,... Gene amplification is determined from the ratio b...n of the HER2 gene probe (red signals) and the num...
...is the only HER-2 assessment test approved by the ...laims: prognosis, adriamycin-based chemotherapy se...l antibody therapy selection. PathVysion is the on...erceptin® package insert as an appropriate tes...
...in Anesthesia and Respiratory Products, ,Westmed ... medical devices for Anesthesia and Respiratory pr...ure products that enhance the clinician's ability ... attention to the bottom line. , ,Our web site is...
...livers breakthrough continuous low-flow nebulizer ...se nozzle technology allows for optimal medication... OMNI~NEB takes on severe asthma, COPD and pneumon...onfigure with a mask, mouth and T-piece to deliver...
Medicine Products: